ZVSA
ZyVersa Therapeutics
ZVSA
ZVSA
Delisted
ZVSA was delisted on the 16th of July, 2025.
24 hedge funds and large institutions have $62.2M invested in ZyVersa Therapeutics in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.02% more ownership
Funds ownership: 0.2% → 0.22% (+0.02%)
Holders
24
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$2.79M | |
| 2 | +$2.32M | |
| 3 | +$1.38M | |
| 4 |
SCM
Saba Capital Management
New York
|
+$1.09M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$521K |
Top Sellers
| 1 | -$1.83M | |
| 2 | -$496K | |
| 3 | -$62.6K | |
| 4 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$20.9K |
| 5 |
KIM
Karpus Investment Management
Pittsford,
New York
|
-$6.92K |